Barcelona | 28 October 2014| A new TB drug with a novel mechanism of action – delamanid - is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis resistant to at least isoniazid and rifampicin, the main first-line drugs. Delamanid was granted conditional approval by the European Medicine Agency in April 2014
Global Appeal 2014 to End Stigma and Discrimination against People Affected by Leprosy was launched in Jakarta, Indonesia, on January 27, endorsed by national human rights institutions from 39 countries and regions.
With cancer, starting the right treatment quickly is key to saving lives. An important requirement of this is being diagnosed at the earliest possible stage. 8.2 million people die from cancer each year around the world and 1.2 million of these are in WHO’s South-East Asia Region, where an estimated 1.7 million new cancer cases are diagnosed each year. For women in the Region, cancer of the breast and cervix are the most common cancers, whilst lung and oral cavity cancers are the most common for men.
Work to ensure that people with disabilities are included in the post-2015 development agenda continues to gain momentum as the UN’s High Level panel releases recommendations for the world’s next development goals. Thanks to the advocacy work of IDDC, of which TLM is a member, and IDA, the report contains numerous mentions of the needs of people with disabilities and specifically includes them in two of the new goals (something that wasn’t achieved with the MDGs).
The Department of Health of the Philippines has launched the first mobile phone-based leprosy referral system in the country. “The Leprosy Alert Response Network System (LEARNS) will be valuable in identifying new leprosy cases, particularly in areas where health access is restricted because of poor communications and geographic isolation,” said Dr Ernesto Villalon, National Leprosy Control Program Manager.
“The fast changing epidemiology of the disease has outpaced anachronistic legislations that no longer reflect societal perceptions of leprosy or the new paradigm of human rights”, writes Rimjhim Jain about leprosy in the Hindustan Times.
Doctors generally check their patients' blood pressure during office visits, but a new study says many are not doing it the right way - and that by doing it incorrectly, the doctors could be putting their patients' lives at risk. Cardiologist Oscar Garfein takes blood pressure readings from both of his patients' arms. That technique saved the life of one of his patients.